Acute lymphoblastic leukaemia has a poor outcome in children with Down syndrome due to infective death in remission - (Results of UK MRC ALL 97 trial).

被引：0
|
作者：
de la Fuente, J
Richards, S
Webb, DK
Hann, IM
Mitchell, CD
Vora, AJ
Kinsey, SE
Eden, OB
Ancliff, P
机构：
[1] Great Ormond St Hosp Children, Dept Haematol, London WC1N 3JH, England
[2] CTSU, Oxford, England
[3] John Radcliffe Hosp, Oxford OX3 9DU, England
[4] Sheffield Childrens Hosp, Dept Haematol, Sheffield S10 2TH, S Yorkshire, England
[5] St James Univ Hosp, Dept Paediat Oncol, Leeds LS9 7TF, W Yorkshire, England
[6] Christie Hosp, Acad Unit Paediat Oncol, Manchester, Lancs, England
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
873
引用
收藏
页码：256A / 257A
页数：2
相关论文
共 50 条
  • [41] Benefit and feasibility of initial lumbar puncture and intrathecal chemotherapy on day 8 of remission induction therapy in children with acute lymphoblastic leukaemia (ALL): the results from the Tokyo Children's Cancer Study Group L99-15 protocol
    Hasegawa, D.
    Manabe, A.
    Ohara, A.
    Koh, K.
    Ogawa, C.
    Hanada, R.
    Tsuchida, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 94 - 94
  • [42] IMPROVED OUTCOME FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA BY PROLONGING THERAPY FOR IKZF1 DELETION AND DECREASING THERAPY FOR ETV6::RUNX1, DOWN SYNDROME OR PREDNISONE POOR RESPONSE
    Pieters, Rob
    De Groot-Kruseman, Hester
    Fiocco, Marta
    Verwer, Femke
    Overveld, Merian
    Sonneveld, Edwin
    Van der Velden, Vincent
    Beverloo, Berna
    Bierings, Marc
    Dors, Natasja
    De Haas, Valerie
    Hoogerbrugge, Peter
    Van der Sluis, Inge
    Tissing, Wim
    Veening, Margreet
    Boer, Judith
    Den Boer, Monique
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S102 - S103
  • [43] TEL/AML1 rearrangement is rare in children with Acute Lymphoblastic Leukemia (ALL) and Down syndrome (DS). Presenting features and treatment outcome in the experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)
    Arico, Maurizio
    Ziino, Ottavio
    Valsecchi, Maria Grazia
    Cazzaniga, Giovanni
    Rizzari, Carmelo
    Barisone, Elena
    Biondi, Andrea
    Casale, Fiorina
    Locatelli, Franco
    Lo Nigro, Luca
    Luciani, Matteo
    Messina, Chiara
    Micalizzi, Concetta
    Parasole, Rosanna
    Pession, Andrea
    Santoro, Nicola
    Testi, Anna Maria
    Silvestri, Daniela
    Basso, Guiseppe
    Masera, Guiseppe
    Conter, Valentino
    BLOOD, 2007, 110 (11) : 260A - 260A
  • [44] Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate-risk acute lymphoblastic leukemia.: Final results of the prospective randomized PETHEMA ALL-89 TRIAL
    Ortega, JJ
    Ribera, JM
    Oriol, A
    Bastida, P
    González, ME
    Calvo, C
    Egurbide, I
    Rivas, JMH
    Rivas, C
    Alcalá, A
    Besalduch, J
    Macía, J
    Gardella, S
    Carnero, M
    Lite, JM
    Casanova, F
    Martinez, M
    Fontanillas, M
    Feliu, E
    San Miguel, JF
    HAEMATOLOGICA, 2001, 86 (06) : 586 - 595
  • [45] in Philadelphia-Chromosome-Negative Acute Lymphoblastic Leukemia, Late Relapses Are Not Uncommon, Occur Mostly in Patients at Standard Risk and Have a Relatively Favorable Outcome. Results of the International ALL Trial: MRC Ukallxii/ECOG E2993
    Ganzel, Chezi
    Victoria, Wang Xin
    Fielding, Adele K.
    Rowe, Jacob M.
    Richards, Susan M.
    Buck, Georgina
    Chopra, Rajesh
    Durrant, I. Jill
    Marks, David
    Franklin, Ian M.
    McMilan, Andrew K.
    Litzow, Mark R.
    Paietta, Elisabeth
    Luger, Selina
    Wiernik, Peter H.
    Douer, Dan
    Lazarus, Hillard M.
    Tallman, Martin S.
    Goldstone, Anthony H.
    BLOOD, 2015, 126 (23)
  • [46] Genomic Correlates of Outcome in a Randomised Comparison of CPX-351 and FLAG-Ida in High-Risk Acute Myeloid Leukaemia and Myelodysplastic Syndrome: Results from the UK NCRI AML19 Trial
    Othman, Jad
    Dillon, Richard
    Wilhelm-Benartzi, Charlotte
    Knapper, Steve
    Batten, Leona M.
    Canham, Joanna
    Hinson, Emily L.
    Villiers, William
    Kleeman, Michelle
    Gilkes, Amanda
    Potter, Nicola
    Overgaard, Ulrik Malthe
    Mehta, Priyanka
    Kottaridis, Panos
    Cavenagh, Jamie
    Hemmaway, Claire
    Arnold, Claire
    Dennis, Mike
    Russell, Nigel H.
    BLOOD, 2022, 140 : 1036 - 1038
  • [47] Dutch ALL11 Study: Improved Outcome for Acute Lymphoblastic Leukemia By Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for ETV6::RUNX1, Down Syndrome and Prednisone Poor Responders
    Pieters, Rob
    De Groot-Kruseman, Hester A.
    Verwer, Femke
    van Overveld, Merian
    Sonneveld, Edwin
    Fiocco, Marta
    van der Velden, Vincent H. J.
    Beverloo, Berna
    Bierings, Marc
    De Haas, Valerie
    Hoogerbrugge, Peter M.
    Van der Sluis, Inge M.
    Tissing, Wim J. E.
    Veening, Margreet
    Boer, Judith M.
    den Boer, Monique L.
    BLOOD, 2022, 140
  • [48] Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy:: Results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Miinster Group 87
    Einsiedel, HG
    von Stackelberg, A
    Hartmann, R
    Fengler, R
    Schrappe, M
    Janka-Schaub, G
    Mann, G
    Hählen, K
    Göbel, U
    Klingebiel, T
    Ludwig, WD
    Henze, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 7942 - 7950
  • [49] HLA-DPβ1 Asp84-Lys69 antigen-binding signature predicts event-free survival in childhood B-cell precursor acute lymphoblastic leukaemia: results from the MRC UKALL XI childhood ALL trial
    G M Taylor
    R Wade
    A Hussain
    P Thompson
    I Hann
    B Gibson
    T Eden
    S Richards
    Blood Cancer Journal, 2012, 2 : e80 - e80
  • [50] HLA-DPβ1 Asp84-Lys69 antigen-binding signature predicts event-free survival in childhood B-cell precursor acute lymphoblastic leukaemia: results from the MRC UKALL XI childhood ALL trial
    Taylor, G. M.
    Wade, R.
    Hussain, A.
    Thompson, P.
    Hann, I.
    Gibson, B.
    Eden, T.
    Richards, S.
    BLOOD CANCER JOURNAL, 2012, 2 : e80 - e80
12345